1. |
World Health Organization. Human infection with pandemic A ( H1N1 ) 2009 influenza virus: clinical observations in hospitalized patients, Americas, July 2009 -update. Wkly Epidemiol Rec, 2009 ,84: 305-308.
|
2. |
Gill JR, Sheng ZM, Ely SF, Guinee DG, et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med, 2010, 134: 235-243.
|
3. |
Mauad T, Hajjar LA, Callegari1 GD, et al. Lung Pathology in Fatal Novel Human Influenza A ( H1N1) Infection. Am JResp Crit Care, 2010, 181: 72-79.
|
4. |
Salomon R, Webster RG. The influenza virus enigma. Cell, 2009 ,136 : 402 -410.
|
5. |
Hui DS, Lee N, Chan PK. Clinical Management of Pandemic ( H1N1 ) Infection. Chest, 2010, 137: 916 -925.
|
6. |
Tang BM, Craig JC, Eslick GD, et al. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis. Crit Care Med, 2009, 37 :1594-1603.
|
7. |
Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA, 2009, 301: 2362-2375.
|
8. |
Chen RC, Tang XP, Tan SY, et al. Treatment of severe scute respiratory syndrome with glueosteroids: the Guangzhou experience.Chest, 2006, 129: 1441-1452.
|
9. |
Quispe-Laime AM, Bracco JD, Barberio PA, et al. H1N1 influenza A virus-associated acute lung injury: response tocombination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med, 2010 , 36: 33 -41 .
|
10. |
代兵, 温华, 谭伟, 等. 新型甲型H1N1 流感重症和危重症病例75 例临床分析. 中国实用内科杂志, 2010, 30 : 7 -9.
|
11. |
Lee N, Allen Chan K, Hui DS, et al. Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. J Clin Virol, 2004, 31: 304-309 .
|
12. |
Lee N, Chan PK, Hui DS, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis,2009, 200: 492-500 .
|
13. |
人禽流感专家组. 中国高致病性禽流感A/ H5N1 病毒感染病例临床管理专家共识( 草案) . 中华结核和呼吸杂志, 2009, 32 :329-334.
|